Structure |
Chemical Name |
CAS |
MF |
 |
Irbesartan Impurity 6 |
|
C25H28N6O |
 |
Empagliflozin impurity B |
|
|
 |
Varenicline Impurity 1 |
|
|
 |
Voriconazole Impurity 6 |
|
|
 |
Caspofungin impurity 1 |
|
|
 |
Cabozantinib impurity D |
|
|
 |
Neratinib Impurity 3 |
|
|
 |
Ranitidine Impurity D |
|
C13H22N4O3S |
 |
Metoprolol IMpurity 5 |
|
C15H25NO3 |
 |
Mirabegron Impurity 2 |
|
|
 |
Pemetrexed Impurity 1 |
1644287-26-2 |
C20H21N5O8 |
 |
Plerixafor Impurity B |
|
|
 |
Tolvaptan impurity3 |
|
|
 |
Vonoprazan Impurity 7 |
|
|
 |
Cefazolin impurity F |
|
|
 |
Apremilast Impurity 3 |
88687-92-7 |
C16H10N2O8 |
 |
Apixaban Impurity 8 |
1777781-49-3 |
C24H23N5O4 |
 |
Ritodrine BP Impurity D |
|
|
![1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)-](/CAS/20180808/GIF/1229512-52-0.gif) |
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
C20H18F3N |
![Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]-](/CAS/20150408/GIF/1365267-37-3.gif) |
Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]- |
1365267-37-3 |
C22H21N3O7 |
 |
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
![1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine](/CAS/20150408/GIF/332374-42-2.gif) |
1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine |
332374-42-2 |
C14H20N2O4S |
 |
Rivaroxaban Impurity 19 |
|
|
 |
Topiroxostat Impurity 4 |
1379342-46-7 |
C8H8N2O3 |
 |
Ertapenem impurity 1 |
|
|
 |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl methacrylate |
|
C26H36NO3 |
 |
Flomoxef Impurity 3 |
|
|
 |
Ropivacaine impurity |
1105704-96-8 |
C12H14N2O3 |
 |
Agomelatine Impurity 1 |
1352139-51-5 |
C15H19NO2 |
 |
Diquafosol Impurity 1 |
26184-65-6 |
C18H24N4O17P2 |
 |
Milnacipran Impurity 3 |
1353644-50-4 |
C15H20ClNO |
 |
L-Glutamic acid 1-ethyl ester |
52454-78-1 |
C7H13NO4 |
 |
Methyl 2-Hydroxy-2-(Thiophen-2-Yl)-2-(Thiophen-3-Yl)Acetate |
28748-67-6 |
C11H10O3S2 |
![6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/20180703/GIF/1812890-23-5.gif) |
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine |
1812890-23-5 |
C13H21N5 |
 |
Sacubitril Impurity 72 |
1361408-16-3 |
C23H27NO4 |
 |
(1R,2S,3R)-Aprepitant |
1185502-97-9 |
C23H21F7N4O3 |
 |
Clemastine |
108825-05-4 |
C21H26ClNO2 |
 |
4-chloro-7-methoxyquinoline-6-carboxylic acid |
771464-30-3 |
C11H8ClNO3 |
![ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/85647-43-4.gif) |
ethyl (41S,13aR)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
85647-43-4 |
C22H26N2O2 |
![methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate](/CAS/20210111/GIF/38990-16-8.gif) |
methyl (41R,12R,13aR)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate |
38990-16-8 |
C21H26N2O3 |
 |
Dolutegravir Impurity 3 |
1973402-05-9 |
C20H19F2N3O5 |
 |
Cistracurium Besylate EP Impurity D |
1075726-88-3 |
C31H39NO9S |
![(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one](/CAS/20180703/GIF/1288338-96-4.gif) |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one |
1288338-96-4 |
C25H25ClN6O2 |
 |
Bendamustine Impurity 8 |
1797881-48-1 |
C14H19Cl2N3O2 |
 |
FeBuxostat Impurity 32 |
1805770-41-5 |
C12H12N2O |
 |
Edoxaban Impurity 9(1R,2S,4S) |
2024614-15-9 |
C21H30ClN5O5 |
 |
Rivaroxaban Impurity 22 |
1350288-77-5 |
C19H18ClN3O5S |
 |
Rivaroxaban Impurity 27 |
1369969-44-7 |
C21H21N3O5 |
 |
Abiraterone Impurity 9 |
165334-72-5 |
C24H31NO |
 |
Gliclazide Impurity A |
|
|
 |
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
 |
Tenofovir Disoproxil Impurity B |
36817-69-3 |
C8H11N5O |
 |
Ipragliflozin IMP |
|
|
 |
2-Propanone, 1,3-bis(4-methoxyphenyl)- |
29903-09-1 |
C17H18O3 |
 |
3-(1-Naphthalenyloxy)propiophenone |
41198-42-9 |
C19H16O2 |
 |
2-(1,3,2-Dioxaborinan-2-yl)benzamide |
2377611-18-0 |
C10H12BNO3 |
 |
Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) |
5740-62-5 |
C24H32O6 |
 |
ApovincaMinic Acid Ethyl Ester N-Oxide |
109741-24-4 |
C22H26N2O3 |
![(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate](/CAS/20150408/GIF/752174-62-2.gif) |
(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate |
752174-62-2 |
C20H25NO2 |
 |
EMpagliflozin iMpurity 12 |
|
|
 |
(2S,4R)-Teneligliptin |
1404559-15-4 |
C22H30N6OS |
 |
Daclatasvir Impurity |
1417333-83-5 |
C40H50N8O6 |
![(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20210111/GIF/65576-39-8.gif) |
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
![1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine](/CAS/20150408/GIF/1293489-74-3.gif) |
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
1293489-74-3 |
C18H22N2S |
 |
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
 |
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
 |
carfilzoMib iMpurity -A |
|
|
 |
(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1593543-00-0 |
C24H21F2NO3 |
![ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate](/CAS/20150408/GIF/1111177-30-0.gif) |
ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
1111177-30-0 |
C26H33N5O3 |
 |
Rosuvastatin EP impurity A |
1714147-50-8 |
C25H34FN3NaO7S* |
 |
Doxorubicin Impurity 6 |
69429-21-6 |
C26H27NO11 |
 |
Etoricoxib Impurity 11 |
202409-31-2 |
C17H13ClN2O2S |
 |
Levofloxacin Tetrafluoro Impurity 1 |
110548-02-2 |
C15H15F4NO4 |
 |
Penicillin F Potassium Salt |
97299-13-3 |
C14H21KN2O4S |
 |
Olaparib Impurity 31 |
458535-34-7 |
C12H18N2O2 |
 |
Macitentan impurity A |
441798-25-0 |
C17H16Br2N6O4S |
 |
4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE OXIME |
152642-35-8 |
C16H13Cl2NO |
 |
3-Pyridinecarboxylic acid, 6-(4-carboxy-1-piperidinyl)-5-chloro- |
958457-83-5 |
C12H13ClN2O4 |
 |
Linagliptin Impurity C |
|
|
 |
Parecoxib Impurity B |
|
|
 |
Vildagliptin impurity E |
|
|
 |
3-propylisobenzofuran-1(3H)-one |
72424-08-9 |
C11H12O2 |
 |
Axitinib Sulfonyl |
1348536-59-3 |
C22H18N4O3S |
 |
Atracurium Impurity B |
87046-74-0 |
|
 |
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
 |
2-(2-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol |
|
C13H13FN6O |
 |
Dapagliflozin Impurity 10 |
960404-86-8 |
C21H25ClO7 |
 |
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
 |
Imatinib Impurity 5 |
|
|
 |
Mirabegron Impurity 8 HCl |
1684452-81-0 |
C21H24N4O2S |
 |
Regorafenib Impurity 2 |
|
|
 |
Vonoprazan Impurity 5 |
|
|
 |
Bendamustine |
1219709-86-0 |
C14H18ClN3O2 |
 |
Dapagliflozin Impurity E |
|
|
 |
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
 |
Kaempferol 3-robinoside 7-glucoside |
114924-89-9 |
C33H40O20 |
 |
Vitexin 7-glucoside |
35109-95-6 |
C27H30O15 |
 |
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
 |
Carfilzomib Impurity B |
|
|
 |
Ornidazole Impurity 1 |
1100750-18-2 |
|